[Suppressive effect of 14-cyclol linkage macrolides on bleomycin-induced pulmonary fibrosis].
Lee
Y
Y
Matsuda
K
K
Aoyama
A
A
Abe
S
S
Shinhara
R
R
Enomoto
T
T
Miyamoto
H
H
Takahashi
T
T
Usuki
J
J
Takahashi
S
S
Azuma
A
A
Kudo
S
S
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001761:Bleomycin; D017291:Clarithromycin / Q000494:pharmacology / Q000627:therapeutic use*; D004195:Disease Models, Animal; D019040:E-Selectin / Q000378:metabolism; D019272:Leukocyte Elastase / Q000502:physiology; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D020556:Neutrophil Infiltration / Q000187:drug effects; D019007:P-Selectin / Q000378:metabolism; D011658:Pulmonary Fibrosis / Q000139:chemically induced / Q000188:drug therapy* / Q000378:metabolism; D015575:Roxithromycin / Q000494:pharmacology / Q000627:therapeutic use*; D019010:Vascular Cell Adhesion Molecule-1 / Q000378:metabolism
D000900:Anti-Bacterial Agents; D019040:E-Selectin; D019007:P-Selectin; D019010:Vascular Cell Adhesion Molecule-1; D001761:Bleomycin; D015575:Roxithromycin; D019272:Leukocyte Elastase; D017291:Clarithromycin